Provided by Tiger Trade Technology Pte. Ltd.

Vir Biotechnology, Inc.

10.18
+0.18001.80%
Post-market: 10.190.0100+0.10%18:40 EDT
Volume:1.44M
Turnover:14.65M
Market Cap:1.64B
PE:-3.22
High:10.25
Open:10.07
Low:9.99
Close:10.00
52wk High:11.66
52wk Low:4.16
Shares:161.23M
Float Shares:119.00M
Volume Ratio:1.03
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1619
EPS(LYR):-3.1619
ROE:-45.73%
ROA:-24.36%
PB:2.14
PE(LYR):-3.22

Loading ...

Apr 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 29, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 10, 2026

Major Issues Report

Form 8-K - Current report
Apr 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2026

Major Issues Report

Form 8-K - Current report
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | VIR BIO's Director Vicki Lee Sato proposes to sell 88,000 shares, with a total value of approximately $799,920.
Mar 02, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 25, 2026

Proposed Sale Of Securities

Form 144 | Vir Biotechnology Stockholder SVF Endurance (Cayman) Limited proposes to sell 400,000 Shares, with a total value of approximately $3.80 Million.
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 25, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 23, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]